[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU46838B - Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa - Google Patents

Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa

Info

Publication number
YU46838B
YU46838B YU22186A YU22186A YU46838B YU 46838 B YU46838 B YU 46838B YU 22186 A YU22186 A YU 22186A YU 22186 A YU22186 A YU 22186A YU 46838 B YU46838 B YU 46838B
Authority
YU
Yugoslavia
Prior art keywords
added
preparation
cooled
procedure
treatment
Prior art date
Application number
YU22186A
Other languages
English (en)
Serbian (sr)
Other versions
YU22186A (en
Inventor
Pero Dr. Višnjić
Original Assignee
Pero Dr. Višnjić
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pero Dr. Višnjić filed Critical Pero Dr. Višnjić
Priority to YU22186A priority Critical patent/YU46838B/sh
Priority to EP86200238A priority patent/EP0196121A1/en
Priority to GR861655A priority patent/GR861655B/el
Priority to PL1986260392A priority patent/PL152379B1/pl
Priority to BG075673A priority patent/BG49705A3/xx
Priority to HU863584A priority patent/HU198841B/hu
Priority to NO863355A priority patent/NO173727C/no
Priority to FI863389A priority patent/FI85945C/fi
Priority to AU63604/86A priority patent/AU602871B2/en
Priority to DK484186A priority patent/DK484186A/da
Publication of YU22186A publication Critical patent/YU22186A/xx
Priority to US07/370,121 priority patent/US5004736A/en
Publication of YU46838B publication Critical patent/YU46838B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

POSTUPAK ZA DOBIJANJE PREPARATA ZA LEČENJE KOŽNE BOLESTI PSORIAZISA, naznačen tim e, što se smeša komponenti, masne podloge, homogenizovanih i otopljenih na temperaturi od 150В°C, ohladi na 85В°C - 90В°C, pri čemu ukupno faza pripreme traje 20 minuta, posle čega se tako dobijena uljana faza dodaje, uz stalno mešanje u demineralizovanu vodu, predhodno sterilisanu i zatim dobijena emulzija steriliše na 85-90В°C, hladi do 50-60В°C, kada se dodaju, uz stalno mešanje, propilen glikol i 9-fluoro-11 17,21-trihidroksi-16 metil-pregna-1,4-dien-3,20-dion-17,21-dipropionat i 6,9-difluoro-11,16,17,21-tetrahidroksi-pregna-1,4-dien-3,20-dion-21-acetat-16,17-acetonid u odnosu 1:1 posle čega se emulzija i dalje hladi do 30-35В°C kada se, uz mešanje dodaju gen-tamicin sulfat u količini koja obezbedjuje 35.000 I.J/100 g masti, vitamin A palmitat u količini koja obezbedjuje 30.000 I.J/100 g masti i 0.5 g 2.4-dihidroksi -N-/3-hidroksi-propil/-3,3-dimetil butilamida, pri čemu se, posle mešanja i homogenizacije, na kraju dodaje salicilna kiselina u količini od 7 mas.% u odnosu na ukupnu masu preparata.
YU22186A 1985-02-22 1986-02-14 Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa YU46838B (sh)

Priority Applications (11)

Application Number Priority Date Filing Date Title
YU22186A YU46838B (sh) 1986-02-14 1986-02-14 Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
EP86200238A EP0196121A1 (en) 1985-02-22 1986-02-18 Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
GR861655A GR861655B (en) 1986-02-14 1986-06-25 Preparation process for a medicine used for the psoriasis treatment and application therefor
PL1986260392A PL152379B1 (en) 1986-02-14 1986-07-01 Procedure for obtaining the preparation for the treatment of the disease psoriasis: drug for the treatment of psoriasis and its application
BG075673A BG49705A3 (en) 1986-02-14 1986-07-09 Method for preparing means for medical psoriasis
HU863584A HU198841B (en) 1986-02-14 1986-08-14 Process for producing composition suitable for treating psoriasis
NO863355A NO173727C (no) 1986-02-14 1986-08-20 Fremgangsmaate for fremstilling av et preparat mot psoriasis
FI863389A FI85945C (fi) 1986-02-14 1986-08-21 Foerfarande foer framstaellning av en produkt avsedd foer skoetsel av sjukdomen psoriasis.
AU63604/86A AU602871B2 (en) 1986-02-14 1986-10-08 Procedure for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
DK484186A DK484186A (da) 1986-02-14 1986-10-10 Fremgangsmaade til fremstilling af et praeparat til behandling af psoriasis
US07/370,121 US5004736A (en) 1986-02-14 1989-06-23 Procedure for obtaining the preparation for the treatment of the disease psoriasis: drug for the treatment of psoriasis and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU22186A YU46838B (sh) 1986-02-14 1986-02-14 Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa

Publications (2)

Publication Number Publication Date
YU22186A YU22186A (en) 1988-08-31
YU46838B true YU46838B (sh) 1994-06-24

Family

ID=25548914

Family Applications (1)

Application Number Title Priority Date Filing Date
YU22186A YU46838B (sh) 1985-02-22 1986-02-14 Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa

Country Status (10)

Country Link
US (1) US5004736A (sh)
AU (1) AU602871B2 (sh)
BG (1) BG49705A3 (sh)
DK (1) DK484186A (sh)
FI (1) FI85945C (sh)
GR (1) GR861655B (sh)
HU (1) HU198841B (sh)
NO (1) NO173727C (sh)
PL (1) PL152379B1 (sh)
YU (1) YU46838B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2061477A1 (en) * 1991-03-25 1992-09-26 Lawrence J. Daher Analgesic composition containing beta-carotene
KR100361240B1 (ko) * 1993-12-21 2003-01-29 쉐링 코포레이션 건선치료용약제학적조성물
US5776920A (en) * 1995-08-02 1998-07-07 Quarles; Ruth Method for treatment of psoriasis
PL191525B1 (pl) * 2002-08-12 2006-06-30 Grabowicz Wlodzimierz Środek farmaceutyczny
ES2258402B1 (es) * 2005-02-09 2007-12-01 Antonio Becerra Carnero Composicion farmaceutica para el tratamiento de la psoriasis y otras afecciones de la piel.
PL409156A1 (pl) 2014-08-11 2016-02-15 Matonis Grzegorz Kompozycja kosmetyczna i/lub farmaceutyczna łagodząca objawy łuszczycy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL257621A (sh) * 1959-11-23
GB1318279A (en) * 1970-12-01 1973-05-23 Ici Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4082846A (en) * 1976-11-18 1978-04-04 University Of Utah Method for treating psoriasis
GB2084465B (en) * 1980-10-06 1984-09-12 Glaxo Group Ltd Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
DE3225848A1 (de) * 1982-07-07 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Kortikoidhaltige zubereitung zur topischen applikation

Also Published As

Publication number Publication date
YU22186A (en) 1988-08-31
NO173727C (no) 1994-01-26
BG49705A3 (en) 1992-01-15
FI863389A (fi) 1987-08-15
FI85945C (fi) 1992-06-25
AU602871B2 (en) 1990-11-01
DK484186D0 (da) 1986-10-10
NO863355D0 (no) 1986-08-20
HU198841B (en) 1989-12-28
HUT43788A (en) 1987-12-28
PL152379B1 (en) 1990-12-31
NO173727B (no) 1993-10-18
US5004736A (en) 1991-04-02
FI863389A0 (fi) 1986-08-21
FI85945B (fi) 1992-03-13
DK484186A (da) 1987-08-15
AU6360486A (en) 1987-08-20
GR861655B (en) 1986-10-30
NO863355L (no) 1987-08-17

Similar Documents

Publication Publication Date Title
Beer et al. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1, 25 dihydroxy vitamin D
WO1997003676A1 (es) Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea
JP3315427B2 (ja) 皮膚炎治療剤
EP0292893A1 (en) Steroid lotion
Meller et al. Mineral and endocrine metabolism during fracture healing in dogs.
Mitchell et al. Glucocorticoid-induced osteoporosis: mechanisms for bone loss; evaluation of strategies for prevention
YU46838B (sh) Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
CA2032733A1 (en) Topical pharmaceutical compositions
Levy et al. Induction of cytosolic receptors for 1α, 25-dihydroxyvitamin D3 in the immature rat uterus by oestradiol
Jenkins et al. The effect of estrogen administration in vivo on the elemental composition of the intraluminal fluids of the seminiferous tubules, rete testis, and epididymis of the rat
US4915973A (en) Method for treating skin diseases
KR20150031233A (ko) 민감화 조성물 및 이용 방법
DE19904801A1 (de) Mittel zur topischen Behandlung von Hauterkrankungen
BG107042A (bg) Двойни инхибитори на синтезата на холестеролов естер и восъчен естер, за лечение на разсройства на мастната жлеза
Johannessen Effects of cortisone on dentinogenesis in mandibular first molars of albino rats
Boyle Bones for the future
KR102046566B1 (ko) 피부 가려움 개선용 화장료 조성물
HARRIS Vitamin D and bone
WO2011066614A1 (en) Liquid compositions comprising vitamin d and uses thereof
JPS6233111A (ja) 養毛組成物
SU1572400A3 (ru) Способ получени мази дл лечени псориаза
JPS62106018A (ja) 高濃度ビタミンｅ水性製剤
Bolton The effect of sex hormones on comb growth in immature pullets
SU1532046A1 (ru) Крем дл рук
Shelling Calcium and phosphorus studies: XIII. The effect of emulsification on the potency of viosterol in the treatment of rickets in children